IDiyas

For the Inventor, By the Inventor

Mannheim, Germany

Max Thiel

USPTO Granted Patents = 36

Average Co-Inventor Count = 5.2

ph-index = 9

Forward Citations = 412(Granted Patents)


Company Filing History:

goldMedal35 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents
silverMedal1 out of 1 
 
C.f. Boehringer & Soehne Gmbh
 patent

Years Active: 1976-1985

Loading Chart...
36 patents (USPTO):Explore Patents
1. 4517183 - N-Substituted aziridine-2-carboxylic acid derivatives (1985-05-14),
2. 4503067 - Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compositions (1985-03-05),
3. 4427680 - 1,2-Dihydroquinolines connected via an oxyalkyl group with a piperidine (1984-01-24),
4. 4397848 - N-Substituted aziridine-2-carboxylic acid immunostimulant derivatives (1983-08-09),
5. 4370323 - 2-Cyanoaziridinyl-(1)-2-substituted-aziridinyl-(1)-methanes (1983-01-25),
6. 4348401 - N-Phenoxyalkylpiperidine derivatives (1982-09-07),
7. 4330549 - Coumarins connected via an oxyalkyl group with a piperidine ring having (1982-05-18),
8. 4284633 - Derivatives of xanthine (1981-08-18),
9. 4258058 - Phenoxyalkylcarboxylic acid compounds and thrombocyte-aggregation (1981-03-24),
10. 4243807 - 4-Phenoxymethyl-piperidines (1981-01-06),
11. 4229464 - Aminopropanol substituted indole compounds and compositions for the (1980-10-21),
12. 4224438 - Adenosine-5'-carboxylic acid amides (1980-09-23),
13. 4212866 - Pharmaceutically active derivatives of (1980-07-15),
14. 4172136 - 3-Nitropyrazole compounds and anti-microbial compositions (1979-10-23),
15. 4153728 - Phenoxyalkylcarboxylic acid compounds and therapeutic compositions (1979-05-08),

Title: **Max Thiel: A Pioneering Inventor from Mannheim, DE**

Introduction

Max Thiel, an accomplished inventor based in Mannheim, Germany, has made significant contributions to the field of pharmaceuticals, holding an impressive portfolio of 36 patents. His work focuses on innovative compounds that address critical health issues, particularly those related to the immune system.

Latest Patents

Among his most recent patents, Thiel has developed N-Substituted aziridine-2-carboxylic acid derivatives. This innovation includes pharmaceutical compositions that utilize a general formula integrating various radicals such as carboxyls, alkoxycarbonyls, and more. These compounds aim to combat diseases associated with a weakened immune system and exhibit promising therapeutic potential. Additionally, he has worked on carbazolyl-(4)-oxypropanolamine compounds designed to enhance treatment options in the pharmaceutical field.

Career Highlights

Thiel's career features notable associations with reputable companies, including Boehringer Mannheim GmbH and C.F. Boehringer & Soehne GmbH. His tenure at these organizations has undoubtedly influenced his innovative pursuits and shaped his expertise in drug development and patent research.

Collaborations

Collaboration has been a crucial element in Thiel's journey as an inventor. He has worked alongside esteemed colleagues such as Wolfgang Kampe and Egon Roesch, contributing to a dynamic exchange of ideas and fostering advancements in their shared field of research.

Conclusion

Max Thiel stands out as a leading inventor in Mannheim, Germany, with a remarkable track record of patents that reflect his dedication to advancing pharmaceutical sciences. His innovative achievements not only enhance medical treatments but also inspire future inventors in the realm of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…